Antibody Information
General Information of This Antibody
| Antibody ID | ANI0DPQXY |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | Humanized Anti-PD-L1 SGN-PDL1V mAb |
|||||
| Organization | Seagen Inc. |
|||||
| Synonyms |
Humanized Anti-PD-L1 SGN-PDL1V mAb
Click to Show/Hide
|
|||||
| Antibody Type | Monoclonal antibody (mAb) |
|||||
| Antigen Name | Programmed cell death 1 ligand 1 (CD274) |
Antigen Info | ||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
SGN-PDL1V [Phase 3]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05208762 | Clinical Status | Phase 1 | ||
| Clinical Description |
A phase 1 study of SGN-PDL1V in advanced solid tumors.
|
||||